4640 Results

People

  1. Saltz
    Saltz
  2. O'Reilly
    O'Reilly
  3. Abou-Alfa
    Abou-Alfa
  4. Kelsen
    Kelsen
  5. Ilson
    Ilson
  6. Kemeny
    Kemeny
  7. Janjigian
    Janjigian
  8. Reidy
    Reidy
  9. Jarnagin
    Jarnagin
  10. D'Angelica
    D'Angelica

Groups

  1. Gastrointestinal Oncology Service (4640)
  2. Solid Tumor Oncology Division (4640)
  3. Department of Medicine (4638)
  4. Center for Pancreatic Cancer Research (2270)
  5. Surgery (1040)
  6. Survivorship Research (992)
  7. Epidemiology and Biostatistics (828)
  8. GSK Faculty (793)
  9. Department of Pathology and Laboratory Medicine (723)
  10. Biostatistics Service (661)
  1. "Gastrointestinal Oncology Service"
Formats
  1. Journal Article (2302)
  2. Meeting Abstract (1841)
  3. Review (139)
  4. Book Section (123)
  5. Editorial (93)
  6. Guidelines (36)
  7. Correspondence (33)
  8. Conference Paper (23)
  9. Miscellaneous (21)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Gastrointestinal Oncology Service (4640)
  2. Solid Tumor Oncology Division (4640)
  3. Department of Medicine (4638)
  4. Center for Pancreatic Cancer Research (2270)
  5. Surgery (1040)
  6. Survivorship Research (992)

More Groups

People
  1. Leonard Saltz (790)
  2. Eileen O'Reilly (780)
  3. Ghassan Abou-Alfa (568)
  4. Nancy Kemeny (543)
  5. David Kelsen (537)
  6. David Ilson (433)

More People

Years
  1. 2025 (118)
  2. 2024 (307)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1276)
  2. Annals of Oncology (320)
  3. Annals of Surgical Oncology (140)
  4. Cancer (127)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1355)
  2. Oxford University Press (447)
  3. Elsevier Inc. (404)
  4. Springer (310)
  5. American Association for Cancer Research (279)
  6. Wiley Blackwell (239)

More Publishers

Results (4640)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prospective molecular evaluation of small cell lung cancer (SCLC) utilizing the comprehensive mutation analysis Program at Memorial Sloan-Kettering Cancer Center (MSKCC)
    Meeting Abstract

    Pietanza, M. C.; Varghese, A.; Won, H.; Rekhtman, N.; Wang, L.; Travis, W. D.; Paik, P. K.; Riely, G. J.; Zakowski, M. F.; Ladanyi, M.; more...
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Pilot trial of an adjuvant pentavalent vaccine for patients with small cell lung cancer (SCLC)
    Meeting Abstract

    Krug, L. M.; Varghese, A.; Ragupathi, G.; George, C.; Sawada, R.; Scholz, W. W.; Hansen, D.; Livingston, P. O.; Delasos, L.; Pietanza, M. C.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Colorectal cancer patients with oligometastatic liver disease: what is the optimal approach?
    Journal Article

    Weiser, M. R.; Jarnagin, W. R.; Saltz, L. B.
    Oncology (Norwalk) (2013)

    Fulltext@MSK | Save
  • Delineating genomic heterogeneity in paired primary and metastatic colorectal cancer by massively parallel sequencing
    Meeting Abstract

    Brannon, A. R.; Vakiani, E.; Scott, S. N.; Sylvester, B.; Kania, K.; Viale, A.; Kemeny, N.; Weiser, M.; Solit, D. B.; Berger, M. F.
    Cancer Research (2013)

    Fulltext@MSK | Save
  • A Phase I study of IMMU-130 (labetuzumab-SN38) anti-CEACAM5 antibody-drug conjugate (ADC) in patients with metastatic colorectal cancer (mCRC)
    Meeting Abstract

    Segal, N. H.; Verghis, J.; Govindan, S.; Maliakal, P.; Sharkey, R. M.; Wegener, W. A.; Goldenberg, D. M.; Saltz, L. B.
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Impact of age on the efficacy of newer adjuvant therapies in patients with stage II/III colon cancer: Findings from the ACCENT aatabase
    Journal Article

    McCleary, N. J.; Meyerhardt, J. A.; Green, E.; Yothers, G.; De Gramont, A.; Van Cutsem, E.; O'Connell, M.; Twelves, C. J.; Saltz, L. B.; Haller, D. G.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A phase 1 study evaluating the combination of an allosteric AKT inhibitor (MK-2206) and trastuzumab in patients with HER2-positive solid tumors
    Journal Article

    Hudis, C.; Swanton, C.; Janjigian, Y. Y.; Lee, R.; Sutherland, S.; Lehman, R.; Chandarlapaty, S.; Hamilton, N.; Gajria, D.; Knowles, J.; more...
    Breast Cancer Research (2013)

    Fulltext@MSK | Save
  • Initial results of a new antibody-drug conjugate (ADC), IMMU-130 (labetuzumab-SN38), in patients with metastatic colorectal cancer (mCRC)
    Meeting Abstract

    Segal, N. H.; Verghis, J.; Govindan, S.; Maliakal, P.; Sharkey, R. M.; Wegener, W. A.; Goldenberg, D. M.; Saltz, L. B.
    European Journal of Cancer (2013)

    Fulltext@MSK | Save
  • The impact of young age on survival in patients with metastatic colorectal cancer: Analysis from the ARCAD Clinical Trials Program
    Meeting Abstract

    Lieu, C.; Renfro, L.; De Gramont, A.; Maughan, T. S.; Seymour, M. T.; Saltz, L.; Goldberg, R. M.; Sargent, D.; Eckhardt, S. G.; Eng, C.
    European Journal of Cancer (2013)

    Fulltext@MSK | Save
  • MEDI4736, an anti-PD-L1 antibody with modified Fc domain: Preclinical evaluation and early clinical results from a phase 1 study in patients with advanced solid tumors
    Meeting Abstract

    Khleif, S.; Lutzky, J.; Segal, N.; Antonia, S.; Blake-Haskins, A.; Stewart, R.; Robbins, P.; Shalabi, A.; Ibrahim, R.; Wolchok, J.
    European Journal of Cancer (2013)

    Fulltext@MSK | Save